Contact Us Today!

617-523-7900

or Use Our Simple Online Form to Give Us Feedback

We welcome your comments and feedback. Please include contact information if you'd like a response.

Did you find this page helpful?





If you would like a response, please include your contact information.

Lucy H.Y. Young, M.D., Ph.D., FACS

Specialties: Retina
Macular Degeneration Unit
Phone Number: 617-573-3710
Fax: 617-573-3698
Location: Mass. Eye and Ear
243 Charles Street
Boston, MA 02114
Office Hours: Monday through Friday, 8:30 a.m. - 5:00 p.m.
Location: Mass. Eye and Ear, Stoneham
One Montvale Avenue
Stoneham, MA 02180
Office Hours:
Language:Mandarin Chinese, Portuguese
Board Certification: Ophthalmology
Ph.D. Ph.D. Biology, Harvard University
M.D. University of Wisconsin School of Medicine
Residency Ophthalmology, Harvard Medical School
Fellowship Vitreoretinal Surgery, Mass. Eye and Ear
Teaching Affiliation Associate Professor of Ophthalmology, Harvard Medical School
Biographical Profile:


Dr. Lucy H. Y. Young is a multilingual retina specialist. She is a Surgeon in the Retina Service at Mass. Eye and Ear, and Associate Surgeon to the Affiliate Staff at Brigham and Women’s Hospital. A foremost expert in the diagnosis and management of uveitis and infectious retinitis, Dr. Young receives referrals from retina specialists throughout New England and delivers lectures both nationally and internationally. She has a particular interest in treating patients with diabetic retinopathy, AIDS-related retinal infections, ocular toxoplasmosis, macular degeneration, retinal detachment, and uveitis.

After receiving a Ph.D. in biology from Harvard University, she obtained her medical degree from the University of Wisconsin School of Medicine. She then completed her ophthalmology residency at Harvard Medical School, followed by a fellowship in vitreoretinal surgery at Mass. Eye and Ear.

A Senior Scientist at Mass. Eye and Ear and Associate Professor of Ophthalmology at Harvard Medical School, Dr. Young conducts research on intravitreal drug toxicities, retinal infections, retinal complications associated with KPro implantation, ocular toxoplasmosis, retinal vascular occlusions, ocular immunology, and HIV-related retinal complications. Currently, she is interested in determining whether there are specific factors that determine disease outcome in patients infected with Toxoplasma gondii. Dr. Young has authored more than 90 peer-reviewed research articles, reviews, and book chapters. Additionally, she has been a member of the investigative team for 25 clinical trial reports.

Committed to the education of medical students, residents, and clinical fellows, Dr. Young has formally supervised over 70 trainees, many of whom have gone on to faculty positions. In addition to helping junior residents interpret fluorescein angiograms, she works with intermediate residents who rotate through her clinics and assist her in surgery and teaches them the basic concepts of retinal detachment surgery, diabetic vitrectomies, and repair of trauma-related vitreoretinal complications. Since 2002, she has served as Director of the Lancaster Course in Ophthalmology, which is the world’s oldest and largest ophthalmic educational and draws ophthalmology practitioners and trainees worldwide.

For her work in ophthalmology education, Dr. Young was recognized with the First Annual Vitreoretinal Fellowship Teaching Award from Mass. Eye and Ear and was nominated for the A. Clifford Barger Award for Excellence in Mentoring from HMS on several occasions. Her clinical expertise has been recognized in America’s Top Ophthalmologists, Best Doctors in America, Top Doctors by US News & World Report, and Boston Top Docs.

Clinical Interests

Diabetic retinopathy, macular degeneration, retinal detachment, trauma-related retinal complications, AIDS-related retinal infections, uveitis, ocular toxoplasmosis, retinal vascular occlusions

Research Interests

Diabetic retinopathy, macular degeneration, retinal detachment, trauma-related retinal complications, AIDS-related retinal infections, uveitis, ocular toxoplasmosis, retinal vascular occlusions, ocular immunology

Publications

For a full publication list, please see her CV.

Transcriptional analysis of murine macrophages infected with different Toxoplasma strains identifies novel regulation of host signaling pathways. Melo MB, Nguyen, Cordeiro C, Hassan MA, Yang N, Mckell R, Rosowski EE, Julien L, Butty V, Darde ML, Ajzenberg D, Fitzgerald K, Young LH, Saeij JPJ. PLOS Pathog. 2013;9(12):e1003779.

Interleukin-6 gene polymorphism (-174 G/C) is associated with Toxoplasmic retinochoroiditis. Cordeiro CA, Moreira PR, Bessa TF, Costa GC, Dutra WO, Campos WR, Orefice F, Young LH, Teixeira AL. Acta Ophthalmol. 2013 Jun; 91(4):e311-4.

Progressive outer retinal necrosis presenting as cherry red spot. Yiu G, Young LH. Ocul Immunol Inflamm. 2012 Oct; 20(5):384-6.

Ocular toxoplasmosis: advanced in detection and treatment. Englander M, Young LH. Int Ophthalmol Clin. 2011 Fall;51(4)53-66.

Increased serum levels of soluble tumor necrosis factor receptor-2 (sTNFR2) in patients with active Toxoplasmic retinochoroiditis. Bessa TF, Cordeiro CA, Goncalves RM, Young LH, Campos WR, Orefice F, Teixeira AL. Braz J Infect Dis. 2012 Nov-Dec;16(6):540-4.

View a list of publications on pubmed.gov »